Afghanistan vs Cape Verde: HIV-positive TB patients on ART (antiretroviral therapy)
Afghanistan
100.0%
in 2024
Cape Verde
100.0%
in 2024
Afghanistan rank
1st
Cape Verde rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Afghanistan
- Cape Verde
How they compare
Afghanistan currently reports 100.0% against 100.0% in Cape Verde, a difference of 0.0%.
The two have swapped places 6 times across 11 shared years of data; in 2012 it was Cape Verde ahead.
Afghanistan ranks 1st and Cape Verde ranks 1st of 144 countries.
Across the 2 decades both report, Afghanistan averaged higher in 1 and Cape Verde in 1.
Head to head by decade
| Decade | Afghanistan | Cape Verde | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 75.0% | 92.7% | 17.7% | Cape Verde |
| 2020s | 100.0% | 90.4% | 9.6% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Afghanistan or Cape Verde?
- Afghanistan, at 100.0% against 100.0% in Cape Verde as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Afghanistan and Cape Verde?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Cape Verde?
- 11 years are reported by both, from 2012 to 2024.
- How do Afghanistan and Cape Verde rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Afghanistan ranks 1st and Cape Verde ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.